Alopecia areata: a new treatment plan

References

• AbellEMunroDDIntralesional treatment of alopecia areata with triamcinolone acetonide by jet injectorBr J Dermatol197388155594686543
   PubMed Web of Science ®Google Scholar
• FerrandoJMoreno-AriasGAMulti-injection plate for intralesional corticosteroid treatment of patchy alopecia areataDermatol Surg200026769069110886282
   PubMed Web of Science ®Google Scholar
• OrentreichNSturmHMWeidmanAIPelzigALocal injection of steroids and hair regrowth in alopeciasArch Dermatol19608289490213731135
   PubMedGoogle Scholar
• MancusoGBalducciACasadioCEfficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trialInt J Dermatol200342757257512839615
   PubMed Web of Science ®Google Scholar
• TostiAPiracciniBMPazzagliaMVincenziCClobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalisJ Am Acad Dermatol2003491969812833016
   PubMed Web of Science ®Google Scholar
• PascherFKurtinSAndradeRAssay of 0.2 percent fluocinolone acetonide cream for alopecia areata and totalis. Efficacy and side effects including histologic study of the ensuing localized acneform responseDermatologica197014131932024250339
   PubMedGoogle Scholar
• PriceVHDouble-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areataJ Am Acad Dermatol1987163 Pt 27307363549809
   PubMed Web of Science ®Google Scholar
• Fiedler-WeissVCTopical minoxidil solution (1% and 5%) in the treatment of alopecia areataJ Am Acad Dermatol1987163 Pt 27457483549811
   PubMed Web of Science ®Google Scholar
• PriceVHTopical minoxidil (3%) in extensive alopecia areata, including long-term efficacyJ Am Acad Dermatol1987163 Pt 27377443549810
   PubMed Web of Science ®Google Scholar
• Fiedler-WeissVCBuysCMEvaluation of anthralin in the treatment of alopecia areataArch Dermatol198712311149114933314718
   PubMedGoogle Scholar
• FiedlerVCWendrowASzpunarGJMetzlerCDeVillezRLTreatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralinArch Dermatol199012667567592140670
   PubMedGoogle Scholar
• StrobelRRohrbornGMutagenic and cell transforming activities of 1-chlor-2,4-dinitrobenzene (DNCB) and squaric-acid-dibutylester (SADBE)Arch Toxicol19804543073147004402
   PubMed Web of Science ®Google Scholar
• WilkersonMGHenkinJWilkinJKSmithRGSquaric acid and esters: analysis for contaminants and stability in solventsJ Am Acad Dermatol1985132 Pt 12292344044949
   PubMed Web of Science ®Google Scholar
• WilkersonMGHenkinJWilkinJKDiphenylcyclopropenone: examination for potential contaminants, mechanisms of sensitization, and photochemical stabilityJ Am Acad Dermatol1984115 Pt 18028076239880
   PubMed Web of Science ®Google Scholar
• OrecchiaGPerfettiLAlopecia areata and topical sensitizers: allergic response is necessary but irritation is notBr J Dermatol199112455092039735
   PubMed Web of Science ®Google Scholar
• OrecchiaGMalagoliPSantagostinoLTreatment of severe alopecia areata with squaric acid dibutylester in pediatric patientsPediatr Dermatol199411165688170854
   PubMed Web of Science ®Google Scholar
• Dall’oglioFNascaMRMusumeciMLTopical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): results of an open-label, paired-comparison, clinical trialJ Dermatolog Treat2005161101415897160
   PubMed Web of Science ®Google Scholar
• AghaeiSTopical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian populationBMC Dermatol20055615918897
   PubMedGoogle Scholar
• FrancomanoMSeidenariSUrticaria after topical immunotherapy with diphenylcyclopropenoneContact Dermatitis200247531031112534538
   PubMed Web of Science ®Google Scholar
• WisemanMCShapiroJMacDonaldNLuiHPredictive model for immunotherapy of alopecia areata with diphencyproneArch Dermatol200113781063106811493099
   PubMedGoogle Scholar
• van der SteenPHvan BaarHMHappleRBoezemanJBPerretCMPrognostic factors in the treatment of alopecia areata with diphenylcyclopropenoneJ Am Acad Dermatol1991242 Pt 12272302007667
   PubMed Web of Science ®Google Scholar
• WeiseKKretzschmarLJohnSMHammHTopical immunotherapy in alopecia areata: anamnestic and clinical criteria of prognostic significanceDermatology199619221291338829494
   PubMed Web of Science ®Google Scholar
• InuiSNakajimaTTodaNItamiSFexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: retrospective analysis of 121 casesJ Dermatol200936632332719500180
   PubMed Web of Science ®Google Scholar
• HerbstVZollerMKisslingSWenzelEStutzNFreyschmidt-PaulPDiphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytesEur J Dermatol200616553754217101475
   PubMed Web of Science ®Google Scholar
• HappleRKleinHMMacherETopical immunotherapy changes the composition of the peribulbar infiltrate in alopecia areataArch Dermatol Res198627832142182873796
   PubMed Web of Science ®Google Scholar
• WasylyszynTKozlowskiWZabielskiSLChanges in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyproneArch Dermatol Res20072995–623123717530266
   PubMed Web of Science ®Google Scholar
• HappleRAntigenic competition as a therapeutic concept for alopecia areataArch Dermatol Res198026711091146446265
   PubMed Web of Science ®Google Scholar
• BeardenWAndersonRTrichiasis associated with prostaglandin analog useOphthal Plast Reconstr Surg2004204320322
   Web of Science ®Google Scholar
• HartJShafranovGHypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprostAm J Ophthalmol2004137475675715059720
   PubMed Web of Science ®Google Scholar
• TostiAPazzagliaMVoudourisSTostiGHypertrichosis of the eyelashes caused by bimatoprostJ Am Acad Dermatol200451Suppl 5S149S15015577756
   PubMed Web of Science ®Google Scholar
• RoseboroughILeeHChwalekJStamperRLPriceVHLack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areataJ Am Acad Dermatol200960470570619293023
   PubMed Web of Science ®Google Scholar
• RossEKBolducCLuiHShapiroJLack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areataJ Am Acad Dermatol20055361095109616310083
   PubMed Web of Science ®Google Scholar
• Coronel-PerezIMRodriguez-ReyEMCamacho-MartinezFMLatanoprost in the treatment of eyelash alopecia in alopecia areata universalisJ Eur Acad Dermatol Venereol201024448148520028444
   PubMed Web of Science ®Google Scholar
• VilaOTCamacho MartinezFMBimatoprost in the treatment of eyelash universalis alopecia areataInt J Trichology201022868821712909
   PubMedGoogle Scholar
• DasSGhoramiRCChatterjeeTBanerjeeGComparative assessment of topical steroids, topical tretenoin (0.05%) and dithranol paste in alopecia areataIndian J Dermatol201055214814920606883
   PubMedGoogle Scholar
• TalpurRVuJBassettRStevensVDuvicMPhase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areataJ Am Acad Dermatol2009614592.e591e59919682769
   PubMed Web of Science ®Google Scholar
• EhsaniAHToosiSSeirafiHCapsaicin vs clobetasol for the treatment of localized alopecia areataJ Eur Acad Dermatol Venereol200923121451145319281605
   PubMed Web of Science ®Google Scholar
• RanganathVKFurstDEDisease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patientRheum Dis Clin North Am200733119721717367700
   PubMed Web of Science ®Google Scholar
• RashidiTMahdAATreatment of persistent alopecia areata with sulfasalazineInt J Dermatol200847885085218717871
   PubMed Web of Science ®Google Scholar
• AghaeiSAn uncontrolled, open label study of sulfasalazine in severe alopecia areataIndian J Dermatol Venereol Leprol200874661161319171984
   PubMed Web of Science ®Google Scholar
• EllisCNBrownMFVoorheesJJSulfasalazine for alopecia areataJ Am Acad Dermatol200246454154411907504
   PubMed Web of Science ®Google Scholar
• TaylorCRHawkJLPUVA treatment of alopecia areata partialis, totalis and universalis: audit of 10 years’ experience at St John’s Institute of DermatologyBr J Dermatol199513369149188547044
   PubMed Web of Science ®Google Scholar
• MohamedZBhouriAJallouliAFazaaBKamounMRMokhtarIAlopecia areata treatment with a phototoxic dose of UVA and topical 8-methoxypsoralenJ Eur Acad Dermatol Venereol200519555255516164707
   PubMed Web of Science ®Google Scholar
• Broniarczyk-DylaGWawrzycka-KaflikADubla-BernerMPrusinska- BratosMEffects of psoralen-UV-A-Turban in alopecia areataSkinmed200652646816603835
   PubMedGoogle Scholar
• Behrens-WilliamsSCLeiterUSchienerRWeidmannMPeterRUKerscherMThe PUVA-turban as a new option of applying a dilute psoralen solution selectively to the scalp of patients with alopecia areataJ Am Acad Dermatol200144224825211174382
   PubMed Web of Science ®Google Scholar
• Al-MutairiN308-nm excimer laser for the treatment of alopecia areataDermatol Surg200733121483148718076615
   PubMed Web of Science ®Google Scholar
• Al-MutairiN308-nm excimer laser for the treatment of alopecia areata in childrenPediatr Dermatol200926554755019840308
   PubMed Web of Science ®Google Scholar
• YooKHKimMNKimBJKimCWTreatment of alopecia areata with fractional photothermolysis laserInt J Dermatol201049784584719627384
   PubMed Web of Science ®Google Scholar
• Ait OurhrouiMHassamBKhoudriITreatment of alopecia areata with prednisone in a once-monthly oral pulseAnn Dermatol Venereol20101378–9514518 French20804894
   PubMed Web of Science ®Google Scholar
• KarBRHandaSDograSKumarBPlacebo-controlled oral pulse prednisolone therapy in alopecia areataJ Am Acad Dermatol200552228729015692475
   PubMed Web of Science ®Google Scholar
• KurosawaMNakagawaSMizuashiMA comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areataDermatology2006212436136516707886
   PubMed Web of Science ®Google Scholar
• NakajimaTInuiSItamiSPulse corticosteroid therapy for alopecia areata: study of 139 patientsDermatology2007215432032417911990
   PubMed Web of Science ®Google Scholar
• FriedliALabartheMPEngelhardtEFeldmannRSalomonDSauratJHPulse methylprednisolone therapy for severe alopecia areata: an open prospective study of 45 patientsJ Am Acad Dermatol1998394 Pt 15976029777767
   PubMed Web of Science ®Google Scholar
• LesterRSKnowlesSRShearNHThe risks of systemic corticosteroid useDermatol Clin19981622772889589201
   PubMed Web of Science ®Google Scholar
• SharmaVKGuptaSTwice weekly 5 mg dexamethasone oral pulse in the treatment of extensive alopecia areataJ Dermatol199926956256510535249
   PubMedGoogle Scholar
• LuggenPHunzikerTHigh-dose intravenous corticosteroid pulse therapy in alopecia areata: own experience compared with the literatureJ Dtsch Dermatol Ges200865375378 German18205838
   PubMed Web of Science ®Google Scholar
• ChartauxEJolyPLong-term follow-up of the efficacy of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia areata totalis or universalisAnn Dermatol Venereol20101378–9507513 French20804893
   PubMed Web of Science ®Google Scholar
• RoyerMBodemerCVabresPEfficacy and tolerability of methotrexate in severe childhood alopecia areataBr J DermatolApril 252011 [Epub ahead of print]
   Web of Science ®Google Scholar
• ShapiroJLuiHTronVHoVSystemic cyclosporine and low-dose prednisone in the treatment of chronic severe alopecia areata: a clinical and immunopathologic evaluationJ Am Acad Dermatol19973611141178996277
   PubMed Web of Science ®Google Scholar
• KimBJMinSUParkKYCombination therapy of cyclosporine and methylprednisolone on severe alopecia areataJ Dermatolog Treat200819421622018608727
   PubMed Web of Science ®Google Scholar
• LeeDHongSKParkSWSerum levels of IL-18 and sIL-2R in patients with alopecia areata receiving combined therapy with oral cyclosporine and steroidsExp Dermatol201019214514719758343
   PubMed Web of Science ®Google Scholar
• GuptaAKEllisCNCooperKDOral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysisJ Am Acad Dermatol1990222 Pt 12422502138175
   PubMed Web of Science ®Google Scholar
• PhillipsMAGravesJENunleyJRAlopecia areata presenting in 2 kidney-pancreas transplant recipients taking cyclosporineJ Am Acad Dermatol2005535 Suppl 1S252S25516227102
   PubMed Web of Science ®Google Scholar
• Dyall-SmithDAlopecia areata in a renal transplant recipient on cyclosporinAustralas J Dermatol19963742262278961599
   PubMedGoogle Scholar
• CerottiniJPPanizzonRGde ViraghPAMultifocal alopecia areata during systemic cyclosporine A therapyDermatology1999198441541710490301
   PubMed Web of Science ®Google Scholar
• DaviesMGBowersPWAlopecia areata arising in patients receiving cyclosporin immunosuppressionBr J Dermatol199513258358367772501
   PubMed Web of Science ®Google Scholar
• SternthalMBMurphySJGeorgeJKornbluthALichtigerSPresentDHAdverse events associated with the use of cyclosporine in patients with inflammatory bowel diseaseAm J Gastroenterol2008103493794318177449
   PubMed Web of Science ®Google Scholar
• GilharAPillarTEtzioniATopical cyclosporin A in alopecia areataActa Derm Venereol19896932522532566234
   PubMed Web of Science ®Google Scholar
• MauduitGLenversPBarthelemyHThivoletJTreatment of severe alopecia areata with topical applications of cyclosporin AAnn Dermatol Venereol19871144507510 French3619297
   PubMed Web of Science ®Google Scholar
• FarshiSMansouriPSafarFKhiabanlooSRCould azathioprine be considered as a therapeutic alternative in the treatment of alopecia areata? a pilot studyInt J Dermatol201049101188119320883409
   PubMed Web of Science ®Google Scholar
• Garcia BartelsNLeeHHWormMBurmesterGRSterryWBlume- PeytaviUDevelopment of alopecia areata universalis in a patient receiving adalimumabArch Dermatol2006142121654165517179003
   PubMedGoogle Scholar
• KirshenCKanigsbergNAlopecia areata following adalimumabJ Cutan Med Surg2009131485019298772
   PubMed Web of Science ®Google Scholar
• ChavesYDuarteGBen-SaidBTebibJBerardFNicolasJFAlopecia areata universalis during treatment of rheumatoid arthritis with anti- TNF-alpha antibody (adalimumab)Dermatology2008217438018849606
   PubMed Web of Science ®Google Scholar
• PelivaniNHassanASBraathenLRHungerREYawalkarNAlopecia areata universalis elicited during treatment with adalimumabDermatology2008216432032318230980
   PubMed Web of Science ®Google Scholar
• EttefaghLNedorostSMirmiraniPAlopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair folliclesArch Dermatol20041408101215313825
   PubMed Web of Science ®Google Scholar
• FabreCDereureOWorsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximabDermatology2008216218518618216487
   PubMed Web of Science ®Google Scholar
• PostenWSwanJRecurrence of alopecia areata in a patient receiving etanercept injectionsArch Dermatol2005141675976015967923
   PubMedGoogle Scholar
• AbramovitsWLosornioMFailure of two TNF-alpha blockers to influence the course of alopecia areataSkinmed20065417718116855408
   PubMedGoogle Scholar
• PanYRaoNAAlopecia areata during etanercept therapyOcul Immunol Inflamm200917212712919412875
   PubMed Web of Science ®Google Scholar
• StroberBESiuKAlexisAFEtanercept does not effectively treat moderate to severe alopecia areata: an open-label studyJ Am Acad Dermatol20055261082108415928633
   PubMed Web of Science ®Google Scholar
• PriceVHHordinskyMKOlsenEASubcutaneous efalizumab is not effective in the treatment of alopecia areataJ Am Acad Dermatol200858339540218280336
   PubMed Web of Science ®Google Scholar
• Ruiz-DobladoSCarrizosaAGarcia-HernandezMJAlopecia areata: psychiatric comorbidity and adjustment to illnessInt J Dermatol200342643443712786868
   PubMed Web of Science ®Google Scholar
• WillemsenRVanderlindenJDeconinckARoseeuwDHypnotherapeutic management of alopecia areataJ Am Acad Dermatol200655223323716844504
   PubMed Web of Science ®Google Scholar
• CiprianiRPeriniGIRampinelliSParoxetine in alopecia areataInt J Dermatol200140960060111737460
   PubMed Web of Science ®Google Scholar
• PeriniGZaraMCiprianiRImipramine in alopecia areata. A double-blind, placebo-controlled studyPsychother Psychosom1994613–41951988066157
   PubMed Web of Science ®Google Scholar
• WillemsenRHaentjensPRoseeuwDVanderlindenJHypnosis in refractory alopecia areata significantly improves depression, anxiety, and life quality but not hair regrowthJ Am Acad Dermatol201062351751820159323
   PubMed Web of Science ®Google Scholar
• HayICJamiesonMOrmerodADRandomized trial of aromatherapy. Successful treatment for alopecia areataArch Dermatol199813411134913529828867
   PubMed Web of Science ®Google Scholar
• HajheydariZJamshidiMAkbariJMohammadpourRCombination of topical garlic gel and betamethasone valerate cream in the treatment of localized alopecia areata: a double-blind randomized controlled studyIndian J Dermatol Venereol Leprol2007731293217314444
   PubMed Web of Science ®Google Scholar
• SasmazSAricanOComparison of azelaic acid and anthralin for the therapy of patchy alopecia areata: a pilot studyAm J Clin Dermatol20056640340616343028
   PubMed Web of Science ®Google Scholar
• ParkHKimCWKimSSParkCWThe therapeutic effect and the changed serum zinc level after zinc supplementation in patients with alopecia areata who had a low serum zinc levelAnn Dermatol200921214214620523772
   PubMed Web of Science ®Google Scholar
• BhatYJManzoorSKhanARQayoomSTrace element levels in alopecia areataIndian J Dermatol Venereol Leprol2009751293119172027
   PubMed Web of Science ®Google Scholar
• LutzGKreyselHWSelective changes in lymphocytic differentiation antigens in the peripheral blood of patients with alopecia areata treated with oral zincZ Hautkr1990652132134 German1971470
   PubMedGoogle Scholar
• SharquieKEAl-ObaidiHKOnion juice (Allium cepa L.), a new topical treatment for alopecia areataJ Dermatol200229634334612126069
   PubMed Web of Science ®Google Scholar
• RobinsDNCase reports: alopecia universalis: hair growth following initiation of simvastatin and ezetimibe therapyJ Drugs Dermatol20076994694717941369
   PubMedGoogle Scholar
• AliAMartinJM4thHair growth in patients alopecia areata totalis after treatment with simvastatin and ezetimibeJ Drugs Dermatol201091626420120427
   PubMed Web of Science ®Google Scholar
• GalbraithGMThiersBHJensenJHoehlerFA randomized double-blind study of inosiplex (isoprinosine) therapy in patients with alopecia totalisJ Am Acad Dermatol1987165 Pt 19779832438319
   PubMed Web of Science ®Google Scholar
• GeorgalaSKatoulisACBefonAGeorgalaKStavropoulosPGInosiplex for treatment of alopecia areata: a randomized placebocontrolled studyActa Derm Venereol200686542242416955187
   PubMed Web of Science ®Google Scholar
• LowyMLedoux-CorbusierMAchtenGWybranJClinical and immunologic response to isoprinosine in alopecia areata and alopecia universalis: association with autoantibodiesJ Am Acad Dermatol1985121 Pt 178842579988
   PubMed Web of Science ®Google Scholar
• RosenbergEWSkinnerRBJrImmunotherapy of alopecia areata with intralesional Candida antigenPediatr Dermatol200623329916780487
   PubMed Web of Science ®Google Scholar
• D’OvidioRClaudatusJDi PrimaTIneffectiveness of imiquimod therapy for alopecia totalis/universalisJ Eur Acad Dermatol Venereol200216441641712224709
   PubMed Web of Science ®Google Scholar
• KocETuncaMAkarAKurumluZLack of efficacy of topical imiquimod in the treatment of patchy alopecia areataInt J Dermatol200847101088108918986369
   PubMed Web of Science ®Google Scholar
• RigopoulosDGregoriouSKorfitisCLack of response of alopecia areata to pimecrolimus creamClin Exp Dermatol200732445645717537231
   PubMed Web of Science ®Google Scholar
• FeldmannKAKunteCWollenbergAWolfeHIs topical tacrolimus effective in alopecia areata universalis?Br J Dermatol200214751031103212410729
   PubMed Web of Science ®Google Scholar
• ParkSWKimJWWangHYTopical tacrolimus (FK506): treatment failure in four cases of alopecia universalisActa Derm Venereol200282538738812430746
   PubMed Web of Science ®Google Scholar
• PriceVHWilleyAChenBKTopical tacrolimus in alopecia areataJ Am Acad Dermatol200552113813915627095
   PubMed Web of Science ®Google Scholar
• ThiersBHTopical tacrolimus: treatment failure in a patient with alopecia areataArch Dermatol2000136112410632221
   PubMedGoogle Scholar
• ChoHRLewBLLewHSimWYTreatment effects of intradermal botulinum toxin type A injection on alopecia areataDermatol Surg201036Suppl 42175218121134049
   PubMed Web of Science ®Google Scholar
• NasiriSHaghpanahVTaheriEHeshmatRLarijaniBSaeediMHair regrowth with topical triiodothyronine ointment in patients with alopecia areata: a double-blind, randomized pilot clinical trial of efficacyJ Eur Acad Dermatol Venereol2011Apr 27 [Epub ahead of print]
   Web of Science ®Google Scholar
• YooKHLeeJWLiKKimBJKimMNPhotodynamic therapy with methyl 5-aminolevulinate acid might be ineffective in recalcitrant alopecia totalis regardless of using a microneedle roller to increase skin penetrationDermatol Surg201036561862220384755
   PubMed Web of Science ®Google Scholar
• Fernandez-GuarinoMHartoAGarcia-MoralesIPerez-GarciaBArrazolaJMJaenPFailure to treat alopecia areata with photodynamic therapyClin Exp Dermatol200833558558718355356
   PubMed Web of Science ®Google Scholar
• BissonnetteRShapiroJZengHMcLeanDILuiHTopical photodynamic therapy with 5-aminolaevulinic acid does not induce hair regrowth in patients with extensive alopecia areataBr J Dermatol200014351032103511069515
   PubMed Web of Science ®Google Scholar
• KaplanALOlsenEATopical 5-fluorouracil is ineffective in the treatment of extensive alopecia areataJ Am Acad Dermatol200450694194315153898
   PubMed Web of Science ®Google Scholar
• WassermanDGuzman-SanchezDAScottKMcMichaelAAlopecia areataInt J Dermatol200746212113117269961
   PubMed Web of Science ®Google Scholar
• MadaniSShapiroJAlopecia areata updateJ Am Acad Dermatol200042454956610727299
   PubMed Web of Science ®Google Scholar
• AlkhalifahAAlsantaliAWangEMcElweeKJShapiroJAlopecia areata update: part II. TreatmentJ Am Acad Dermatol201062219120220115946
   PubMed Web of Science ®Google Scholar
• RossEKShapiroJManagement of hair lossDermatol Clin200523222724315837153
   PubMed Web of Science ®Google Scholar